Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by MAP4K4 is a member of the serine/threonine protein kinase family. Additionally we are shipping MAP4K4 Proteins (6) and MAP4K4 Kits (1) and many more products for this protein.
Showing 10 out of 159 products:
Human Monoclonal MAP4K4 Primary Antibody for ELISA, WB - ABIN969274
Becker, Huynh-Do, Holland, Pawson, Daniel, Skolnik: Nck-interacting Ste20 kinase couples Eph receptors to c-Jun N-terminal kinase and integrin activation. in Molecular and cellular biology 2000
Show all 3 Pubmed References
Human Monoclonal MAP4K4 Primary Antibody for ELISA, WB - ABIN969275
Poinat, De Arcangelis, Sookhareea, Zhu, Hedgecock, Labouesse, Georges-Labouesse: A conserved interaction between beta1 integrin/PAT-3 and Nck-interacting kinase/MIG-15 that mediates commissural axon navigation in C. elegans. in Current biology : CB 2002
Show all 3 Pubmed References
Human Monoclonal MAP4K4 Primary Antibody for ELISA, WB - ABIN966520
Bouzakri, Zierath: MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor-alpha-induced insulin resistance. in The Journal of biological chemistry 2007
Show all 5 Pubmed References
Human Monoclonal MAP4K4 Primary Antibody for IHC (p), ELISA - ABIN564078
Ma, Baumgartner: Filopodia and membrane blebs drive efficient matrix invasion of macrophages transformed by the intracellular parasite Theileria annulata. in PLoS ONE 2013
Show all 2 Pubmed References
Human Polyclonal MAP4K4 Primary Antibody for IHC, IHC (p) - ABIN4317265
Rizzardi, Rosener, Koopmeiners, Isaksson Vogel, Metzger, Forster, Marston, Tiffany, McCarthy, Turley, Warlick, Henriksen, Schmechel: Evaluation of protein biomarkers of prostate cancer aggressiveness. in BMC cancer 2014
Human Polyclonal MAP4K4 Primary Antibody for ICC, IF - ABIN439089
Xu, Takanashi, Oikawa, Nishi, Isaka, Yoshimoto, Ohyashiki, Kuroda: Identification of a novel role of Septin 10 in paclitaxel-resistance in cancers through a functional genomics screen. in Cancer science 2012
Results reveal that endothelial Map4k4 is critical for lymphatic vascular development by regulating endothelial cells (EC)quiescence and lymphatic EC fate.
of the five variants, SNP rs2236935T/C was significantly associated with type 2 diabetes mellitus (T2DM) in this study population; conclude that MAP4K4 gene is associated with T2DM in a Chinese Han population, and MAP4K4 gene variants may contribute to the risk toward the development of T2DM
Interactions between MAP4K4 gene variants and environmental factors may contribute to MAP4K4 attenuation in T cells, leading to non-obese T2D.
MAP4K4 promotes the epithelial-mesenchymal transition and invasiveness of hepatocellular carcinoma cells
miR (show MLXIP Antibodies)-194 regulated the progression of hepatocellular carcinoma through directly inhibiting the expression of MAP4K4
The results of the present study suggested that inhibition of MAP4K4 may be a therapeutic strategy for gastric cancer.
loss of MAP4K4 function suppressed pathological angiogenesis in disease models, identifying MAP4K4 as a potential therapeutic target
that MAP4K4, a known mediator of inflammation, is involved in KS aetiology by regulating KSHV lytic reactivation
results reveal a key target of SOX2 (show SOX2 Antibodies) expression and highlight the unexpected context-dependent role for MAP4K4, a pluripotent activator of several mitogen-activated protein kinase (show MAPK1 Antibodies) pathways, in regulating tumor cell survival.
TRAF1.NIK is a central complex linking canonical and non-canonical pathways by disrupting the TRAF2-cIAP2 ubiquitin ligase complex
Blood endothelial Map4k4 promotes vascular dysfunction and impairs glucose homeostasis in adult animals, lymphatic endothelial Map4k4 is required to maintain lymphatic vascular integrity and regulate immune cell trafficking in obesity.
These results demonstrate that protein kinase (show CDK7 Antibodies) Map4k4 drives obesity-induced hyperinsulinemia and insulin (show INS Antibodies) resistance in part by promoting insulin (show INS Antibodies) secretion from beta cells in mice.
These results reveal that MAP4K4 is a key signalling node that promotes immune cell recruitment in atherosclerosis.
Mice with Map4k4 deleted in Myf5 (show MYF5 Antibodies)-positive tissues, including all skeletal muscles tested, were protected from obesity-induced glucose intolerance and insulin (show INS Antibodies) resistance.
HGK/MAP4K4 deficiency has a role in inducing TRAF2 (show TRAF2 Antibodies) stabilization and Th17 differentiation leading to insulin (show INS Antibodies) resistance
microtubules can deliver MAP4K4 toward focal adhesions through ending binding 2
MAP4K4 is essential for CD4 (show CD4 Antibodies)+ T cell proliferation and activation in vitro through suppressing PKC-theta (show PRKCQ Antibodies) activation.
Map4k4 inhibits adipose lipogenesis by suppression of Srebp-1 (show SREBF1 Antibodies) in an AMPK (show PRKAA1 Antibodies)- and mTOR (show FRAP1 Antibodies)-dependent but JNK (show MAPK8 Antibodies)-independent mechanism.
Expression of a Map4k4 kinase-inactive mutant enhances myotube formation, suggesting that the kinase activity of Map4k4 is essential for its inhibition of muscle differentiation.
study identified single nucleotide polymorphisms at different locations of mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4) gene of cattle and several of them were significantly associated with the somatic cell score and other different milk traits
The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase has been shown to specifically activate MAPK8/JNK. The activation of MAPK8 by this kinase is found to be inhibited by the dominant-negative mutants of MAP3K7/TAK1, MAP2K4/MKK4, and MAP2K7/MKK7, which suggests that this kinase may function through the MAP3K7-MAP2K4-MAP2K7 kinase cascade, and mediate the TNF-alpha signaling pathway. Alternatively spliced transcript variants encoding different isoforms have been identified.
HPK/GCK-like kinase HGK
, MAPK/ERK kinase kinase kinase 4
, MEK kinase kinase 4
, Ste20 group protein kinase HGK
, hepatocyte progenitor kinase-like/germinal center kinase-like kinase
, nck-interacting kinase
, MEKKK 4
, NCK interacting kinase
, mitogen activated protein kinase kinase kinase kinase 4